The Boots Group (PRIVATE.BOOTS)

Overall impact
A (87)

Commentary

The Boots Group is a leader for overall positive impact. With an 'A' rating of 86.6 for overall impact (98th percentile compared to all companies), The Boots Group ranks 1st out of 21 industry peers, ahead of Rite Aid, Cosmos Pharmaceutical, Photocure and 17 others. On top material causes for The Boots Group's industry (Consumer Staples Distribution & Retail), The Boots Group performs well in Racial Justice and Civil Rights (92.9 score), Accountable Institutions (94.9), Fair Labor Practices (95.1) and 14 other causes where it received an 'A' score and performs poorly in Reduced Green House Gas Emissions (24.3 score).
Impact
Cause PRIVATE.BOOTS
Peer rank
Overall impact

Log in to view this information

Impact trend

Change in rating for overall impact

Log in to view this information

Company
Employees
66,400
Sector
Consumer Staples
Industry
Consumer Staples Distribution & Retail
Sub-industry
Drug Retail
SASB industry
Drug Retailers
Headquarters
United Kingdom
Share classes
PRIVATE.BOOTS
Description
The Boots Group is a healthcare, pharmacy, and retail company with a long heritage (176 years). It operates across 11 countries, including the UK, Ireland, Thailand and Mexico, serving millions daily through owned stores, equity investments and franchise partners. Its principal retail brands include Boots (UK, Thailand, ROI), Farmacias Benavides (Mexico) and Boots Opticians (UK). In Germany, it runs a major pharmaceutical wholesale division under Alliance Healthcare Deutschland and GEHE, supporting pharmacies nationwide. The No7 Beauty Company within the group manages science‑led beauty brands such as No7, Liz Earle, Soap & Glory, Botanics, Sleek MakeUP and Aromatherapy Associates. The group also holds strategic retail pharmacy/wholesale investments in China and has franchise presence in the Middle East and Indonesia.
Material causes
Ethos considers the following causes material for The Boots Group, based on its industry sub-industry Drug Retail. Learn more about material causes in our methodology overview.

This information is subject to Ethos' Terms and Conditions, which you can find here.

This information may not be used for corporate financing purposes (including, without limitation, ESG-linked loans, credit facilities, securities or structured products), as a basis for any financial instruments or products (including, without limitation, passively managed funds and index-linked derivative securities) or other products or services, to verify or correct data in any other compilation of data or index, to create any derivative works, nor to create any other data or index (custom or otherwise), without Ethos' prior written permission.

By browsing this site you agree to our use of cookies. Read more.
We use cookies on this site to enhance your user experience. By continuing to browse the site, you are agreeing to our use of cookies. Give me more info.